Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy

被引：0
|
作者：
Mari Yokoi
Daiki Tsuji
Kenichi Suzuki
Yohei Kawasaki
Masahiko Nakao
Hideaki Ayuhara
Yuuki Kogure
Kazuhiko Shibata
Toshinobu Hayashi
Keita Hirai
Kazuyuki Inoue
Toshihiro Hama
Koji Takeda
Makoto Nishio
Kunihiko Itoh
机构：
[1] University of Shizuoka,Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences
[2] Cancer Institute Hospital,Department of Pharmacy, Japanese Foundation for Cancer Research
[3] University of Shizuoka,Department of Drug Evaluation and Informatics, School of Pharmaceutical Sciences
[4] Osaka City General Hospital,Department of Pharmacy
[5] Tokyo Medical University Hospital,Department of Pharmacy
[6] National Hospital Organization Shikoku Cancer Center,Department of Pharmacy
[7] Kouseiren Takaoka Hospital,Department of Medical Oncology
[8] National Hospital Organization Kyushu Medical Center,Department of Pharmacy
[9] Osaka City General Hospital,Department of Clinical Oncology
[10] Cancer Institute Hospital,Department of Thoracic Medical Oncology, Japanese Foundation for Cancer Research
来源：
Supportive Care in Cancer | 2018年 / 26卷
关键词：
Chemotherapy-induced nausea and vomiting (CINV); polymorphism; Cisplatin; Granisetron; Palonosetron; Aprepitant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1505 / 1513
页数：8
相关论文
共 50 条
  • [41] Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer
    Einhorn, Lawrence H.
    Brames, Mary J.
    Dreicer, Robert
    Nichols, Craig R.
    Cullen, Michael T., Jr.
    Bubalo, Joseph
    SUPPORTIVE CARE IN CANCER, 2007, 15 (11) : 1293 - 1300
  • [42] Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer
    Lawrence H. Einhorn
    Mary J. Brames
    Robert Dreicer
    Craig R. Nichols
    Michael T. Cullen
    Joseph Bubalo
    Supportive Care in Cancer, 2007, 15 : 1293 - 1300
  • [43] PATIENT-REPORTED AND GENETIC RISK FACTORS FOR CHEMOTHERAPY-INDUCED NAUSEA IN CANCER PATIENTS
    Hyland, Kelly A.
    Nelson, Ashley M.
    Bell, Gillian
    Gray, Jhanelle
    Kim, Richard
    Jacobsen, Paul B.
    McLeod, Howard L.
    Jim, Heather
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1872 - S1873
  • [44] Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy
    Affronti, Mary Lou
    Bubalo, Joseph
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 329 - 337
  • [45] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [46] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
  • [47] Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy
    Gao, H. F.
    Liang, Y.
    Zhou, N. N.
    Zhang, D. S.
    Wu, H. Y.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (01) : 73 - 76
  • [48] Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy
    Eliasen, Astrid
    Kornholt, J.
    Mathiasen, R.
    Brok, J.
    Rechnitzer, C.
    Schmiegelow, K.
    Dalhoff, K.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1361 - 1368
  • [49] Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
    Shimokawa, Mototsugu
    Haratake, Naoki
    Takada, Kazuki
    Toyokawa, Gouji
    Takamori, Shinkichi
    Mizuki, Fumitaka
    Takenaka, Tomoyoshi
    Hayashi, Toshinobu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2673 - 2680
  • [50] Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors
    Sonam Puri
    Kelly A. Hyland
    Kristine Crowe Weiss
    Gillian C. Bell
    Jhanelle E. Gray
    Richard Kim
    Hui-Yi Lin
    Aasha I. Hoogland
    Brian D. Gonzalez
    Ashley M. Nelson
    Anita Y. Kinney
    Stacy M. Fischer
    Daneng Li
    Paul B. Jacobsen
    Howard L. McLeod
    Heather S. L. Jim
    Supportive Care in Cancer, 2018, 26 : 2911 - 2918
12345